Yiling Pharmaceutical's subsidiary, Wanyang Hengshui Pharmaceutical Co., Ltd., has received approval from China's National Medical Products Administration for its Irbesartan chemical raw material drug application. Irbesartan is an angiotensin II receptor blocker used to treat primary hypertension and type 2 diabetic nephropathy. In other news, JD Pharmacy (Dalian) Co., Ltd. was established with a registered capital of 100,000 RMB, focusing on medical device and pharmaceutical sales, and is wholly owned by JD Pharmacy (Qingdao) Chain Co., Ltd. AI
RANK_REASON The cluster contains a product approval for a pharmaceutical drug and the establishment of a new pharmacy company, which are not frontier AI releases or significant industry-wide events.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
